Literature DB >> 15364552

Advances in stent technology and drug-eluting stents.

Nicolas Nelken1, Peter A Schneider.   

Abstract

From an initially simple concept, vascular stents have evolved into highly specialized instruments, and are poised to develop into sophisticated drug-delivery systems. Although primary research has mostly targeted the coronary circulation, newer generation stents, deliverable almost anywhere, retarding neointimal hyperplasia and thrombosis, and promoting endothelial overgrowth, will offer the next approximation of true vascular healing. This, in turn,promises to promote less invasive, safer, and finally durable endovascular solutions to current surgical problems.

Entities:  

Mesh:

Year:  2004        PMID: 15364552     DOI: 10.1016/j.suc.2004.05.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

Review 1.  Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal:  Appl Biochem Biotechnol       Date:  2011-09-27       Impact factor: 2.926

2.  Enhanced endothelialization on surface modified poly(L-lactic acid) substrates.

Authors:  Hao Xu; Rajendrasing Deshmukh; Richard Timmons; Kytai Truong Nguyen
Journal:  Tissue Eng Part A       Date:  2010-12-18       Impact factor: 3.845

3.  Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.

Authors:  Charlie C-T Hsu; Gigi Nc Kwan; Dalveer Singh; John A Rophael; Chris Anthony; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2018-12-08

4.  Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study.

Authors:  Marianne Brodmann; Christian Wissgott; Andrew Holden; Robert Staffa; Thomas Zeller; Thodur Vasudevan; Peter Schneider
Journal:  Catheter Cardiovasc Interv       Date:  2018-03-24       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.